McMullin, Mary Frances
Belfast Health and Social Care Trust,
United Kingdom
2025 Rank: 61230
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1171 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 61230 | 59205 |
| Total Cites | 884 | 1012 |
| H-index | 13 | 14 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 27 | 30 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 80 | 92 |
| Number of Single+First+Last Authored Papers | 127 | 127 |
| Total Cites to Single+First+Last Authored Papers | 155 | 168 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 618 | 670 |
| Ratio of Total Citations to Distinct Citing Papers | 1.43 | 1.51 |
| Self-Citation Percentage |
12.65%
|
|
McMullin, Mary Frances
Queen's University Belfast,
United Kingdom
2024 Rank: 58492
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1179 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 58492 | 57559 |
| Total Cites | 818 | 945 |
| H-index | 14 | 14 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 29 | 29 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 84 | 92 |
| Number of Single+First+Last Authored Papers | 124 | 124 |
| Total Cites to Single+First+Last Authored Papers | 150 | 172 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 588 | 633 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.49 |
| Self-Citation Percentage |
13.44%
|
|
McMullin, Mary Frances
Queen's University Belfast,
United Kingdom
2023 Rank: 57905
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1277 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 57905 | 59833 |
| Total Cites | 841 | 919 |
| H-index | 14 | 16 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 20 | 20 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 94 | 97 |
| Number of Single+First+Last Authored Papers | 119 | 119 |
| Total Cites to Single+First+Last Authored Papers | 182 | 189 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 599 | 630 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.46 |
| Self-Citation Percentage |
8.49%
|
|
McMullin, Mary Frances
Queen's University Belfast,
United Kingdom
2022 Rank: 37761
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 977 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 37761 | 38579 |
| Total Cites | 1009 | 1135 |
| H-index | 16 | 16 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 19 | 19 |
| Total Cites to Single Authored Papers | 32 | 33 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 106 | 115 |
| Number of Single+First+Last Authored Papers | 119 | 119 |
| Total Cites to Single+First+Last Authored Papers | 208 | 230 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 640 | 695 |
| Ratio of Total Citations to Distinct Citing Papers | 1.58 | 1.63 |
| Self-Citation Percentage |
11.10%
|
|
McMullin, Mary Frances
Queen's University Belfast,
United Kingdom
2021 Rank: 44485
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1045 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 44485 | 44503 |
| Total Cites | 1362 | 1592 |
| H-index | 19 | 19 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 18 | 18 |
| Total Cites to Single Authored Papers | 41 | 41 |
| Number of Single+First Authored Papers | 53 | 53 |
| Total Cites to Single+First Authored Papers | 132 | 143 |
| Number of Single+First+Last Authored Papers | 117 | 117 |
| Total Cites to Single+First+Last Authored Papers | 279 | 315 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 922 | 1027 |
| Ratio of Total Citations to Distinct Citing Papers | 1.48 | 1.55 |
| Self-Citation Percentage |
14.45%
|
|
McMullin, Mary Frances
Queen's University Belfast,
2020 Rank: 61850
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1343 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 61850 | 58469 |
| Total Cites | 881 | 1068 |
| H-index | 14 | 16 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 17 | 17 |
| Total Cites to Single Authored Papers | 27 | 29 |
| Number of Single+First Authored Papers | 51 | 51 |
| Total Cites to Single+First Authored Papers | 81 | 95 |
| Number of Single+First+Last Authored Papers | 111 | 111 |
| Total Cites to Single+First+Last Authored Papers | 160 | 186 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 658 | 746 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.43 |
| Self-Citation Percentage |
17.51%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.